Comparative effectiveness of buprenorphine-naloxone and methadone for opioid overdose among youths

No abstract available.

View Source

Information

Citation

Kleinman RA, Larney S, Sule NO, Ma C, Szatmari P, Kurdyak P. JAMA Pediatr. 2026; Mar 9 [Epub ahead of print].

View Source

Contributing ICES Scientists

Paul Kurdyak

Research Programs

Mental Health & Addictions

Associated Topics

Associated Sites

ICES Central

Discover More

Journal Article

31/03/2026

The effectiveness of the palivizumab programme in reducing the risk of paediatric asthma: a population-based study in Ontario, Canada

Foley KA, Buchan SA, McNally D, Dimitris M, Swayze S, Kwong JC, Hawken S, Saxena S, Hargreaves D, Fitzpatrick T. Paediatr Perinat Epidemiol. 2026; Mar 31 [Epub ahead of print].

Journal Article

25/03/2026

Impact of risk mitigation measures on oral fluoroquinolone prescribing: a multi-site population-based Canadian cohort study

Lix LM, Dahl M, St-Jean A, Golandouz HM, Ling V, Janzen D, Ronksley PE, Scory TD, Dutton DJ, Manning D, Carney G, Perras C, Ernst P; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Arch Public Health. 2026; Mar 25 [Epub ahead of print].

Journal Article

21/03/2026

Safer opioid supply initiation among First Nations Peoples in Ontario, Canada, 2019 to 2023

Ledlie S, Rebić N, Hamzat B, Wang T, Bragg S, Iacono A, Shearer D, General Z, Mecredy G, McGregor L, Bertram J, Pine K, Corbiere Y, Smoke A, Gomes T. Int J Drug Policy. 2026; 151:105243. Epub 2026 Mar 21.

See All